Weed Inc (PK:BUDZ)

Business Focus: Biotechnology & Medical Research

Dec 21, 2023 09:00 am ET
HEMP BioSciences Inc. a Wholly-owned Division of WEED Inc. Receives Full Suite of Industrial Hemp Licenses From State of Arizona
via IBN – WEED Inc. (OTCQB: BUDZ), (“WEED,” “HEMP” or the “Company”), a global cannabis and hemp bioresearch company based in the U.S. focused on the development and application of cannabis–derived compounds for the treatment of human and animal...
Nov 30, 2023 06:00 am ET
WEED Inc Announces Exit from Colorado Cannabis Marketplace with Sale of Sangre Biosciences 4-Acre Campus & Hilltop Headquarters for $3.1 million
TUCSON, AZ / ACCESSWIRE / November 30, 2023 / WEED Inc. (OTCQB:BUDZ), ("WEED" or the "Company") a global cannabis & hemp bioresearch company based in the USA, focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases, to expand into "consumer packaged goods" utilizing our rare Landrace strains including Original Panama Red, Acapulco Gold, Red Bud Colombian & Santa Marta Gold !
May 17, 2023 05:00 pm ET
WEED Australia Ltd is Proud to Announce the Appointment of Ms. Amanda Brunskill-Scott and Mrs. Nicole Breen as Members of our Board of Directors
Ms. Brunskill-Scott will also take over the role of Managing Director and Corporate Secretary, while Mrs. Breen will take over the additional role and responsibilities of treasurer.
Jul 20, 2022 12:50 pm ET
WEED Inc. (USA) Acquires Hempirical Genetics LLC, w/Over 250 Proprietary Cannabis & Hemp Strains for $750,000.00
HEMP BioSciences Inc., a wholly-owned Division of WEED Inc will oversee our Genetics Programs. Panama Red, Acapulco Gold, Red Bud Colombian & Santa Marta Gold top the list.
May 04, 2022 02:45 pm ET
WEED Australia Ltd. is Honored to be Invited and Attend the United in Compassion 2022 Australian Medicinal Cannabis Symposium!
WEED Australia Ltd., w/non-profit arm, The Cannabis Institute of Australia, is attending the United in Compassion Australian Medicinal Cannabis Symposium May 20-22, 2022 on the sunshine coast in northern Queensland.
May 03, 2022 11:30 am ET
WEED Australia Ltd., a Public Company and Fully Reporting Under Australian Securities and Investment Commission (ASIC) Rules, Completes Five Full Years of Audited Financials
WEED Australia Ltd. is a majority (>99%) owned subsidiary of WEED, Inc (USA) and one of the first public Cannabis companies in Australia established in March 2017.
Apr 07, 2022 04:00 pm ET
WEED, Inc. Expands WEED(R) Brand and Adds PANAMA RED(TM) and ACAPULCO GOLD(TM) to its Growing Trademark Portfolio
Brand Expansion is a Key Part of the Company's Growth Plan for Securing Intellectual Property Rights in the Cannabis Industry Globally
Jan 18, 2022 01:25 pm ET
Dec 02, 2021 12:10 pm ET
WEED, Inc. (OTC:BUDZ) PAYS OFF BIG, Laying Groundwork to Enter the New York Cannabis Marketplace
TUCSON, AZ / ACCESSWIRE / December 2, 2021 / WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), a cannabis and hemp bioresearch company based in the USA, announced today that it has completed the purchase of the Sugar Hill Golf Course with the Final Payment of ~$250,000 including all back taxes owed. The property was appraised by an independent appraisal company for $1.9 million in 2019. WEED plans to move forward, preparing filings for licenses in Hemp and eventually high THC research when funds are available, for strain identification, cultivation, proces
Oct 13, 2021 02:25 pm ET
WEED, Inc. (OTC:BUDZ) Creates HEMP BioSciences Inc. to Invest, Research, Cultivate and Develop New Strains & Commercial Products in the "Cannabinoids" Sector
TUCSON, AZ / ACCESSWIRE / October 13, 2021 / WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), a cannabis and hemp bioresearch company based in the USA, announced today that WEED's CEO, Glenn E. Martin has completed the formation of HEMP BioSciences Inc., as an Arizona corporation wholly owned by its parent WEED, Inc.
Mar 24, 2021 06:00 am ET
WEED, Inc. (OTC:BUDZ) to Present its $40 Million RegA+ Offering at Starlight Capital’s Investment & Technology Conference tomorrow March 25th, 2021
TUCSON, AZ / ACCESSWIRE / March 24, 2021 / WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), one of the top cannabis and hemp bioresearch companies based in the USA, announced today that WEED Chief Executive Officer Glenn E. Martin will present at Starlight Capital's virtual conference tomorrow, March 25th between 12 noon and 2PM EDT. Martin will announce WEED's opportunities to invest in a new $40M financing round in BUDZ under Regulation A, Tier 2 as recently qualified by the Securities and Exchange Commission (
Feb 24, 2021 06:00 am ET
WEED, Inc. Launches $40 Million Offering To Fuel Expansion, Acquisitions
TUCSON, AZ / ACCESSWIRE / February 24, 2021 / WEED, Inc. (OTCQB:BUDZ) ("WEED" or the "Company"), one of the top cannabis and hemp bioresearch companies in the USA, announced today the launch of a new $40M financing round under Regulation A, Tier 2 as recently qualified by the Securities and Exchange Commission (See WEED, Inc. Offering Circular Here.)
Nov 11, 2020 02:20 pm ET
WEED Inc. 'SALUTES' our Veterans & Arizona's Historic VOTE
Congratulations: New Jersey, Montana, South Dakota & MississippiFully legal in 15 States , "ALL Fifty States in 50 Months" #LegalizeNow
Sep 05, 2019 02:00 pm ET
WEED, Inc. Is Now DWAC/FAST Eligible
TUCSON, AZ / ACCESSWIRE / September 5, 2019 / WEED, Inc. (OTCQB: BUDZ), a global Cannabis holding company focused on the development and application of cannabis-derived compounds for the treatment of human diseases, announced today that The Depository Trust Company (the "DTC") has approved its common stock for DWAC/FAST transfer through the Company's Transfer Agent, Pacific Stock Transfer Company.
Sep 05, 2019 01:30 pm ET
WEED, Inc. Continues Trademark Portfolio Development
TUCSON, AZ / ACCESSWIRE / September 5, 2019 / WEED, Inc. (OTCQB:BUDZ), the holding company focused on the development and application of cannabis-derived compounds for the treatment of human diseases has continued its pursuit of developing and acquiring intellectual property rights, including trademark rights in its various brands.
Aug 26, 2019 02:23 pm ET
WEED Inc., The FIRST American Cannabis Public Company “Down Under” is Honored to Present & Speak at the Pharmacy Guild of Australia’s National Conference “Pharmacy Connect 2019”
WEED, Inc. (OTCQB: BUDZ) (OTCMarkets.com), a global Cannabis holding company focused on the development and application of cannabis-derived compounds for the treatment of human and animal diseases, today announced that its subsidiary, WEED...
Jul 10, 2019 01:25 am ET
WEED, Inc. Takes Important First Step to Enter New York Market
WEED, Inc. wins bid to acquire property in New York with unlimited water extraction rights
May 22, 2019 02:30 pm ET
WEED Inc. and WEED Australia Ltd. Were Proud Sponsors of the Nimbin 2019 MardiGrass Rally
WEED Inc. and its subsidiaries WEED Australia Ltd., WEED Hong Kong Limited along with WEED Israel Cannabis Ltd. were proud sponsors of the 2019 MardiGrass Cannabis law reform rally & gathering in Nimbin N.S.W.
Mar 20, 2019 06:00 am ET
WEED, Inc. Signs First-of-its-Kind Agreement on Key Cannabis-Related Intellectual Property in Israel
WEED, Inc. and Yissum (of the Hebrew University of Jerusalem) sign first-of-its-kind deal for exclusive license, assignment and transfer to WEED Inc. of groundbreaking intellectual property for novel technologies and formulations of cannabis-related and cannabinoid-based products
Mar 07, 2019 06:00 am ET
WEED, Inc. Signs First-of-its-Kind Agreement on Key Cannabis-Related Intellectual Property in Israel
WEED, Inc. and Yissum (of the Hebrew University of Jerusalem) sign first-of-its-kind deal for exclusive license, assignment and transfer to WEED Inc. of groundbreaking intellectual property for novel technologies and formulations of cannabis-related and cannabinoid-based products
Dec 11, 2018 10:55 am ET
WEED Inc. Completes Proprietary Cannabis Genomics Pilot Study
WEED's ''End-of-Year Scientific Research Conference'' brings successful results to it's 5-year Comprehensive Cannabis Integrated Molecular Breeding Platform
Oct 18, 2018 11:55 am ET
WEED, Inc. Acquires WEED(R) Trademarks
Acquisition of the Trademarks Part of the Company's Plan to Acquire Intellectual Property Relevant to the Industry when Practical
Sep 10, 2018 05:55 am ET
WEED Inc. Expands Global Footprint By Entering Israel & Australia
WEED, Inc. Forms WEED Israel (Cannabis) Ltd, WEED Australia Ltd, and Cannabis Institute of Australia...
Aug 13, 2018 12:30 pm ET
WEED, Inc. S-1 Registration Statement Declared Effective by Securities and Exchange Commission
TUCSON, AZ / ACCESSWIRE / August 13, 2018 / WEED, Inc. (OTC PINK: BUDZ) (the "Company" or "WEED"), a current alternative reporting public company focused on the development and application of cannabis-derived compounds for the treatment of human disease, announced that its Form S-1 resale registration statement relating to the resale of up to 8,982,015 shares of its common stock by certain selling shareholders (the "S-1") was declared effective by the Securities and Exchange Commission on August 8, 2018 at 4pm Eastern Time.
Mar 13, 2018 05:40 pm ET
WEED, Inc. Completes Purchase of Colorado Bioscience Property and Completes First Board of Directors Meeting in 2018
Subsidiary, Sangre AgroTech, Receives Commercial Redevelopment Permit for BioScience Research Center in La Veta, Colorado
Mar 13, 2018 04:30 pm ET
WEED, Inc. Announces the Appointment of Dr. Patrick E. Williams to Its Board of Directors
Dr. Williams is the President and Chief Science Officer of Sangre AT, LLC (dba "Sangre AgroTech"), a wholly-owned subsidiary of the Company. In that capacity, Dr. Williams oversees Sangre's Cannabis Genomic Study, including genomic sequencing, genetics-based breeding, plant tissue culture, and plant biochemistry, utilizing some of the most advanced sequencing and analytical technologies and proprietary bioinformatics data systems available. In addition to serving on the Company's Board of Directors, Dr. Williams will oversee genomic studies and clinical trials for the Company worldwide.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.